4//SEC Filing
Renaud Ronald C JR 4
Accession 0000950170-23-039169
CIK 0001805387other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 5:13 PM ET
Size
5.7 KB
Accession
0000950170-23-039169
Insider Transaction Report
Form 4
Renaud Ronald C JR
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2023-08-03$23.96/sh+83,857$2,008,811→ 83,857 total(indirect: By Trust)
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.78 - $24.01. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Shares held by The Ronald C Renaud Jr Trust 2 U/A DTD 06/08/2007, of which the Reporting Person and his spouse serve as trustees. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001354434
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 5:13 PM ET
- Size
- 5.7 KB